The NTAGI chief’s remarks came after the Drugs Controller General of India’s Subject Expert Committee (SEC) recommended Emergency Use Authorization to Hyderabad-based pharmaceutical company Biological E’s Covid-19 vaccine, Corbevax, for the age group 12 to 18 years subject to certain conditions., The NTAGI chief’s remarks came after the Drugs Controller General of India’s Subject Expert Committee (SEC) recommended Emergency Use Authorization to Hyderabad-based pharmaceutical company Biological E’s Covid-19 vaccine, Corbevax, for the age group 12 to 18 years subject to certain conditions., , Read More
AAS Yoga
Go for Euphoria – Illness to Wellness the Natural Way